-
Telehealth for Disease Management: A Scoping Review of Effectiveness in the Perinatal Period
Mar 10, 2025, 14:00 PM -
The Real-World Cost-Effectiveness of Faricimab Versus Existing and Future Biosimilars in Patients with Neovascular Age-Related Macular Degeneration in Canada
Mar 10, 2025, 14:00 PM -
Investigating the Potential of Extracting Answers to Health-Related Quality of Life Questionnaires From Patient Community Data
Mar 10, 2025, 14:00 PM -
Health-Related Quality of Life and Productivity Losses Across Stages of Breast and Colorectal Cancer
Mar 10, 2025, 14:00 PM -
Assessing the Relationship Between Pruritus and Work Productivity Among Individuals With PBC and Pruritus: Results From the ITCH-E Study
Mar 10, 2025, 14:00 PM -
Analysis of the Epidemiological Burden of Osteoarthritis in Hungary Based on Data From the Global Burden of Disease Study
Mar 10, 2025, 14:00 PM -
Provider perspectives on the DREAMM-7 Trial Results and Belantamab Mafodotin (belamaf) in Combination with Bortezomib and Dexamethasone (B-Vd) as a Potential Treatment for Patients with Relapsed or Refractory Multiple Myeloma (R/R MM)
Mar 10, 2025, 14:00 PM -
Avoidable Costs by the Inclusion Ff Finerenone in Terms of Hospitalization Due to Heart Failure (HF) and the Progression of Chronic Kidney Disease (CKD) in Type 2 Diabetes (T2D) in Colombia
Mar 10, 2025, 14:00 PM -
Revolutionizing Multi-Level Network Meta-Regression: Advancing Analysis With the Package
Mar 10, 2025, 14:00 PM -
Eosinophilic Esophagitis-Related Healthcare Resource Utilization and Associated Costs for Payers and Patients: A Retrospective Cohort Study of US Health Insurance Claims Data
Mar 10, 2025, 14:00 PM -
Marginal Healthcare Expenditure Burden of Patients With Substance Use Disorder In The United States
Mar 10, 2025, 14:00 PM -
An Analysis of Hospitalization Metrics After Intravenous (IV) Ferric Derisomaltose (FDI) versus Usual Care (UC) in Patients with Iron Deficiency Anemia (IDA) and Heart Failure (HF) Based on IRONMAN
Mar 10, 2025, 14:00 PM -
Budget Impact Analysis of Revumenib for the Treatment of Relapsed or Refractory Acute Leukemias With a KMT2A Translocation in the United States
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness Analysis of Sunvozertinib as a Second-line Treatment for Advanced Non-Small Cell Lung Cancer with EGFR exon20ins Mutation: An Economic Evaluation Based on MAIC
Mar 10, 2025, 14:00 PM -
Measuring and Reporting Health-Related Quality of Life (HRQoL) in Locally Advanced/Metastatic Urothelial Cancer (La/mUC) Research: Capturing Outcomes That Really Matter to Patients
Mar 10, 2025, 14:00 PM -
A Retrospective Real-World Data Analysis of Pregnancy Outcomes Among Women with a History of Hysteroscopic Intrauterine Adhesiolysis (HA), Other Intrauterine Surgery (IUs), or no Prior IUs
Mar 10, 2025, 14:00 PM -
Socio-Economic and Behavioural Impacts of COVID-19 Vaccine Mandates: A Scoping Review
Mar 10, 2025, 14:00 PM -
AMCP Dossier v5.0: U.S. Payer Preferences and Utilization to Support Formulary Decision Making
Mar 10, 2025, 14:00 PM -
Real-World Health-Related Quality of Life and Treatment Satisfaction in Patients With High-Risk Non-Muscle Invasive Bladder Cancer
Mar 10, 2025, 14:00 PM -
Impact of Adverse Event Definitions on Real-World Detection of Oncology Immune-Related Adverse Events
Mar 10, 2025, 14:00 PM